Västra Hamnen Market Focus: Bioextrax: Which would you like to hear first?


21 oktober, 10:30

  • Production increase from 100 to 300 tons of PHA per year from Konspec
  • Project with the chemical company delayed, exclusivity removed
  • We keep our fair value of SEK 4.23 per share

Good news and bad news caused some turbulence in the share price of Bioextrax recently. The good news is that Konkan Specialty Products is planning to produce more PHA than previously thought. The bad news is that the commercial agreement with one of the world’s three largest chemical companies is being delayed.

Read the full update here.

About Market Focus

The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.

This is a press release from Västra Hamnen Corporate Finance AB. 
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån